What to Do When BCBS Blue Cross Blue Shield Denies Wegovy: Appeal Strategy
Blue Cross Blue Shield is a federation of 33 independent licensees, and each one writes its own GLP-1 coverage policy.
Backorder GLP-1: How Long Will the Wait Be
When the pharmacy says “we have it on backorder” it could mean a few different things, and the time horizon for each is wildly different.
Back to School on GLP-1: Managing Medication as a Parent
The back-to-school transition is one of the harder seasonal shifts for parents on GLP-1 medications.
AstraZeneca Obesity Pipeline: What’s Coming
AstraZeneca arrived late to the obesity drug race.
Are Online GLP-1 Programs Safe: 2026 Honest Assessment
Introduction Online GLP-1 programs can be safe when they use state-licensed clinicians, source from registered compounding or retail pharmacies, screen patients for contraindications, and…
AOD-9604: Can You Stack It with GLP-1 Medications?
The question comes up often in peptide forums and clinic intake calls.
AOD-9604 What the Research Actually Says: Evidence Review
AOD-9604 has one of the most lopsided gaps in the peptide world between what marketing copy promises and what the published literature shows.
AOD-9604 How It Works: Mechanism of Action Explained Simply
AOD-9604 is a 16-amino-acid peptide carved out of the tail end of human growth hormone. The name AOD stands for Anti-Obesity Drug.
AOD-9604 Dosing Protocol: Cycling, Frequency & Best Practices
AOD-9604 has no FDA-approved dose because it has no FDA-approved indication.
